help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1127
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/11/4709    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Binder, G.
Right arrow Articles by Eggermann, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binder, G.
Right arrow Articles by Eggermann, T.
Related Collections
Right arrow Pediatric Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 11 4709-4712
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

IGF-II Serum Levels Are Normal in Children with Silver-Russell Syndrome Who Frequently Carry Epimutations at the IGF2 Locus

G. Binder, A.-K. Seidel, K. Weber, M. Haase, H. A. Wollmann, M. B. Ranke and T. Eggermann

University Children’s Hospital, 72076 Tübingen, Germany; and Institute of Human Genetics, University Hospital, Rheinisch-Westfälische Technische Hochschule Aachen, 52074 Aachen, Germany

Address all correspondence and requests for reprints to: PD Dr. Gerhard Binder, Pediatric Endocrinology Section, University-Children’s Hospital, Hoppe-Seyler-Strasse1, 72076 Tübingen, Germany. E-mail: gerhard.binder{at}med.uni-tuebingen.de.

Context: Epigenetic mutations of 11p15 encompassing IGF2 are present in short children with Silver-Russell syndrome (SRS) with high frequency (31–50%). It has been speculated that these mutations characterized by demethylation of ICR1 cause diminished IGF2 expression.

Objective: We aimed to determine the prevalence of pathologically low IGF-II serum levels in children with SRS.

Subjects: SRS was defined by birth weight or length below the 3rd percentile, lack of postnatal catch-up growth, and the presence of two of the following characteristics: typical face, relative macrocephaly, and skeletal asymmetry. Serum samples of 30 patients were available. Mean age was 5.4 ± 2.1 yr.

Methods: The serum levels of IGF-I, IGF-II, IGF binding protein (IGFBP)-2, and IGFBP-3 were measured by RIA and compared with age-related reference values and with serum concentrations measured in age- and gender-matched controls born small for gestational age (SGA), but lacking major dysmorphic features. Analysis of genomic DNA was possible in a subgroup of children with SRS: the methylation status of the ICR1 locus on 11p15 and the parental origin of chromosome 7 were analyzed in 9 and 23 children, respectively.

Results: Demethylation of ICR1 was found in 44% and uniparental disomy in 17% of the tested children with SRS. The median IGF-II serum level in SRS was 441 µg/liter (range, 238–875). This was significantly higher than in the SGA controls: 387 µg/liter (range, 265–596) (P < 0.03), but below the median value of the age-related reference, which was 532 µg/liter. The four children with SRS and ICR1 demethylation had high-normal and normal IGF-II serum levels that were higher than the levels of their SGA controls. IGF-I, IGFBP-2, and IGFBP-3 serum levels were not different between the SRS children and their SGA controls.

Conclusions: Our data render it unlikely that demethylation of ICR1 on 11p15 does cause diminished IGF-II serum levels in children with SRS. This observation does not exclude deficient IGF-II action before birth.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. Murphy, J. Baptista, J. Holly, A. M. Umpleby, S. Ellard, L. W. Harries, J. Crolla, T. Cundy, and A. T. Hattersley
Severe Intrauterine Growth Retardation and Atypical Diabetes Associated with a Translocation Breakpoint Disrupting Regulation of the Insulin-Like Growth Factor 2 Gene
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4373 - 4380.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Binder, A.-K. Seidel, D. D. Martin, R. Schweizer, C. P. Schwarze, H. A. Wollmann, T. Eggermann, and M. B. Ranke
The Endocrine Phenotype in Silver-Russell Syndrome Is Defined by the Underlying Epigenetic Alteration
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1402 - 1407.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S Abu-Amero, D Monk, J Frost, M Preece, P Stanier, and G E Moore
The genetic aetiology of Silver-Russell syndrome
J. Med. Genet., April 1, 2008; 45(4): 193 - 199.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Netchine, S. Rossignol, M.-N. Dufourg, S. Azzi, A. Rousseau, L. Perin, M. Houang, V. Steunou, B. Esteva, N. Thibaud, et al.
11p15 Imprinting Center Region 1 Loss of Methylation Is a Common and Specific Cause of Typical Russell-Silver Syndrome: Clinical Scoring System and Epigenetic-Phenotypic Correlations
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3148 - 3154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society